Bolt Biotherapeutics
Jason Ptacek is currently the Director of Translational Science and Biomarkers at Bolt Biotherapeutics, Inc. Previously, Jason held positions in various companies such as IONpath Inc., BioSeek, Nodality Inc., and Stanford University School of Medicine. With a background in Immunology and Molecular Biophysics and Biochemistry, Jason has extensive experience in leading research projects, developing predictive biomarkers, and utilizing innovative technologies in the analysis of cell signaling in oncology and autoimmune diseases. Jason has a proven track record of collaborating on high-dimensional datasets, co-authoring publications, and presenting data to facilitate therapeutics development.
This person is not in any teams
Bolt Biotherapeutics
7 followers
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients.